Dermoplast FIRST AID ANTIBACTERIAL SPRAY
Subpotent Drug: Low assay observed in one of the two active ingredients during stability testing.
Sub- or super-potent product, or a failed content-uniformity / assay test. You may receive too little or too much active ingredient - a direct dosing risk.
992 FDA drug recalls with this cause, newest first.
These recalls cover sub-potent or super-potent products, or a failed content-uniformity test - meaning some pills in the same batch held noticeably different amounts of active ingredient than others. Either way it is a direct dosing risk: too little to work, or too much and harmful. Thyroid hormones and compounded injectables are the classic examples, because their dose window is narrow.
Subpotent Drug: Low assay observed in one of the two active ingredients during stability testing.
Subpotent Drug
Subpotent Drug
Subpotent Drug
Subpotent Drug
Subpotent Drug
Subpotent Drug
Subpotent Drug
Subpotent Drug
Subpotent Drug
Subpotent Drug
Subpotent Drug
Subpotent Drug
Subpotent Drug
Subpotent Drug
Subpotent Drug
Subpotent Drug: Low assay result observed during long-term stability testing.
Subpotent Drug: Out of specification for assay at the 18-month stability timepoint.
Subpotent Drug: repackaged product was recalled by the manufacturer for subpotency.
Subpotent Drug
Subpotent Drug: Testing results below the defined limit for the epinephrine portion of this product.
Subpotent Drug: Testing results below the defined limit for the epinephrine portion of this product.
Subpotent Drug: Testing results below the defined limit for the epinephrine portion of this product.
Subpotent drug: Out of specification for assay at the end-of-shelf-life 24-month period.
Subpotent Drug: The batches contain less than 90% of the labeled amount of latanoprost.
Free recall alerts
Tell us what you take. When FDA posts a recall announcement or classifies a recall for one of your medications, we email you in plain English, with what to check. No account needed.